Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.60 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.59 |
| ▸ | F2 | P00734 | 4/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.58 |
| ▸ | CCKBR | P32239 | 2/20 | 0.57 |
| ▸ | GLP1R | P43220 | 2/20 | 0.57 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.55 |
| ▸ | GNRHR | P30968 | 1/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | TACR1 | P25103 | 1/20 | 0.54 |
| ▸ | CALCR | P30988 | 2/20 | 0.54 |
| ▸ | NMBR | P28336 | 1/20 | 0.54 |
| ▸ | GRPR | P30550 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30527917 | 0.89 | GLP1R (0.66) | CXCR4F2CCKBRGLP1RCXCL8 | |
| SCHEMBL29416022 | 0.89 | CXCR4 (0.72) | CXCR4C5AR1CCKBRGLP1R | |
| SCHEMBL31182778 | 0.87 | GLP1R (0.68) | CXCR4C5AR1CCKBRGLP1RCALCR | |
| SCHEMBL30595218 | 0.87 | GNRHR (0.64) | CXCR4C5AR1F2OPRD1CXCL8 | |
| SCHEMBL30362528 | 0.87 | C5AR1 (0.55) | CXCR4C5AR1F2OPRD1GNRHR | |
| SCHEMBL30572393 | 0.87 | C5AR1 (0.61) | C5AR1CCKBRGLP1RGNRHRKISS1R | |
| SCHEMBL29749763 | 0.86 | C5AR1 (0.68) | CXCR4C5AR1GLP1RGNRHR | |
| SCHEMBL30072008 | 0.86 | F2 (0.64) | C5AR1F2CCKBRGLP1RCXCL8 | |
| SCHEMBL30216268 | 0.86 | F2 (0.67) | CXCR4F2OPRD1CCKBRGLP1R | |
| SCHEMBL29416081 | 0.86 | DPP3 (0.58) | CXCR4CXCL8GNRHRKISS1ROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-116785403-A | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |